Page last updated: 2024-10-30

methenamine and Carcinoma, Hepatocellular

methenamine has been researched along with Carcinoma, Hepatocellular in 2 studies

Methenamine: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
hexamethylenetetramine : A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CARDNO, SS1
STEINER, JW1
Della Porta, G1
Colnaghi, MI1
Parmiani, G1

Other Studies

2 other studies available for methenamine and Carcinoma, Hepatocellular

ArticleYear
IMPROVEMENT OF STAINING TECHNICS FOR THIN SECTIONS OF EPOXY-EMBEDDED TISSUE.
    American journal of clinical pathology, 1965, Volume: 43

    Topics: Acrylic Resins; Biopsy; Carcinoma, Hepatocellular; Coloring Agents; Glycogen; Jejunum; Kidney; Liver

1965
Non-carcinogenicity of hexamethylenetetramine in mice and rats.
    Food and cosmetics toxicology, 1968, Volume: 6, Issue:6

    Topics: Adenoma; Animals; Body Weight; Carcinoma; Carcinoma, Hepatocellular; Endocrine System Diseases; Fema

1968